“Long COVID” Haunts Many People After Their Recovery 30/10/2020 Svĕt Lustig Vijay It is “imperative” that governments recognize the long-term effects of COVID-19 and ensure that affected people can access health services, including primary health care as well as rehabilitation, emphasized the World Health Organization on Friday. “Although we are still learning about this virus, what’s clear is that this is not just a virus that kills […] Continue reading -> Novel SARS-CoV-2 variant spread across Europe in summer 2020 30/10/2020 Editorial team University of Basel. Researchers from Basel and Spain have identified a novel SARS-CoV-2 variant that has spread widely across Europe in recent months, according to an un-peer-reviewed preprint released this week in medRixv. While there is no evidence of this variant being more dangerous, its spread may give insights into the efficacy of travel policies […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Novel SARS-CoV-2 variant spread across Europe in summer 2020 30/10/2020 Editorial team University of Basel. Researchers from Basel and Spain have identified a novel SARS-CoV-2 variant that has spread widely across Europe in recent months, according to an un-peer-reviewed preprint released this week in medRixv. While there is no evidence of this variant being more dangerous, its spread may give insights into the efficacy of travel policies […] Continue reading -> Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Sanofi and GSK Offer Future COVID-19 Vaccine Supplies to WHO Co-sponsored COVAX Facility 29/10/2020 Madeleine Hoecklin Sanofi and GlaxoSmithKline, two drugmakers, announced that they would provide 200 million doses of their potential COVID-19 vaccine to the WHO and Gavi Alliance co-sponsored COVAX procurement facility, which more than 180 countries have joined. “To address a global health crisis of this magnitude, it takes unique partnerships. The commitment we are announcing today for […] Continue reading -> Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Women With COVID-19 May Have More Post-Birth Complications, New Study Suggests 23/10/2020 Raisa Santos A milestone study has found that women giving birth when they are infected with COVID-19, even if asymptomatic, may have more post-birth complications, including fever and hypoxia leading to hospital readmission, as compared to women who are not infected. The study, conducted by Malavika Rabhu of Weill Cornell Medicine, observed 675 women admitted for delivery […] Continue reading -> Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Human Challenge Trials: Frivolous Risk Or Practical Solution To COVID-19 Quandaries? 22/10/2020 Elaine Ruth Fletcher While most of us hope that if we can just get one vaccine to market that will be enough to solve our global COVID-19 matrix – the controversial ‘human challenge’ studies now getting underway highlight how many more twists and turns we are likely to face before we finally get out of the pandemic maze. […] Continue reading -> Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Leading US Expert Anthony Fauci: ‘Cautiously Optimistic’ About COVID-19 Vaccine Approval This Month Or Next 21/10/2020 Raisa Santos America’s most-respected public health guru, Dr Anthony Fauci, said Wednesday that he is “cautiously optimistic’ that at least one COVID-19 vaccine will prove to be safe and effective later this month or next. While warning that “one can never guarantee a safe and effective vaccine… we are cautiously optimistic that we will have one based […] Continue reading -> Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Much-Touted Remdesivir Fails To Reduce COVID-19 Deaths; Results Of WHO-Coordinated Solidarity Trial 16/10/2020 Elaine Ruth Fletcher & Madeleine Hoecklin Two more experimental COVID-19 drugs, including the much-touted Remdesivir, appear to have fallen by the wayside, failing to show significant reductions in mortality among seriously ill patients. Interim results on Remdesivir and three other drug treatments being studied as part of the WHO Solidarity Therapeutics Trial, the world’s largest randomized controlled trial of COVID-19 drugs, […] Continue reading -> China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
China’s Inactivated COVID-19 Vaccine Candidate Is Safe and Provokes Immune Response, Say Preliminary Clinical Trial Results 16/10/2020 Madeleine Hoecklin A new study published in The Lancet on Thursday found that an inactivated vaccine candidate, called BBIBP-CorV, was safe and provoked an immune response in healthy individuals. This is the first study of an inactivated COVID-19 vaccine to include participants over 60 years of age. The BBIBP-CorV vaccine is being developed by the Beijing Institute of […] Continue reading -> First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
First Case Of COVID-19 Reinfection In The US Confirmed; Exposure to Virus May Not Guarantee Protective Immunity, Says New Lancet Study 13/10/2020 Madeleine Hoecklin A study confirming the first case of a person reinfected with COVID-19 in the US and the fifth such confirmed case of reinfection worldwide was published in The Lancet Infectious Diseases journal on Monday. The findings suggest that protected immunity conferred by infection with SARS-CoV2 – a phenomenon that is not well understood yet – […] Continue reading -> Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Neurological Symptoms and Brain Disorders Upend Recovery Of Significant Numbers Of COVID-19 Survivors 12/10/2020 Madeleine Hoecklin Cognitive symptoms are being reported by thousands of COVID-19 survivors, even those with mild symptoms and no previous medical conditions. The symptoms often include memory loss, confusion, difficulty focusing, and dizziness. A study published just last week covering more than 500 hospitalized patients in Chicago, found that some 82% had experienced neurological symptoms at some point […] Continue reading -> Posts navigation Older postsNewer posts